August 17 (SeeNews) - Bosnian pharmaceuticals producer Bosnalijek [SAJ:BSNLR] said on Thursday it turned to a net loss of 9.8 million marka ($5.5 million/5 million euro) in the first half of 2023 after booking a net profit of 18.6 million marka in the like period of last year.